Skip to main content
. 2021 Sep 13;116(1):52. doi: 10.1007/s00395-021-00893-5

Fig. 1.

Fig. 1

Overview of IMPACT criteria for improving the preclinical evaluation of novel cardioprotective interventions. IRI ischaemia/reperfusion injury, MI myocardial infarct, MVO microvascular obstruction